ARRAIL GROUP LTD. (I1D) - Net Assets
Based on the latest financial reports, ARRAIL GROUP LTD. (I1D) has net assets worth €1.78 Billion EUR (≈ $2.09 Billion USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.16 Billion ≈ $3.69 Billion USD) and total liabilities (€1.38 Billion ≈ $1.61 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore I1D cash generation efficiency to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.78 Billion |
| % of Total Assets | 56.43% |
| Annual Growth Rate | 3.46% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.76 |
ARRAIL GROUP LTD. - Net Assets Trend (2022–2025)
This chart illustrates how ARRAIL GROUP LTD.'s net assets have evolved over time, based on quarterly financial data. Also explore I1D total assets for the complete picture of this company's asset base.
Annual Net Assets for ARRAIL GROUP LTD. (2022–2025)
The table below shows the annual net assets of ARRAIL GROUP LTD. from 2022 to 2025. For live valuation and market cap data, see ARRAIL GROUP LTD. market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €1.78 Billion ≈ $2.09 Billion |
-2.92% |
| 2024-03-31 | €1.84 Billion ≈ $2.15 Billion |
+8.34% |
| 2023-03-31 | €1.70 Billion ≈ $1.98 Billion |
+5.30% |
| 2022-03-31 | €1.61 Billion ≈ $1.88 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ARRAIL GROUP LTD.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18075800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €5.25 Billion | 306.11% |
| Total Equity | €1.71 Billion | 100.00% |
ARRAIL GROUP LTD. Competitors by Market Cap
The table below lists competitors of ARRAIL GROUP LTD. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Suzhou Goldengreen Technologies Ltd
SHE:002808
|
$111.31 Million |
|
KEYEAST.Co.Ltd
KQ:054780
|
$111.40 Million |
|
Lithium Chile Inc
V:LITH
|
$111.42 Million |
|
Frontier Energy Ltd
AU:FHE
|
$111.46 Million |
|
Poh Kong Holdings Bhd
KLSE:5080
|
$111.27 Million |
|
Bank Qnb Indonesia Tbk
JK:BKSW
|
$111.25 Million |
|
Merkur PrivatBank KgaA
XETRA:MBK
|
$111.24 Million |
|
Leo Systems
TWO:5410
|
$111.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ARRAIL GROUP LTD.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,755,167,000 to 1,713,865,000, a change of -41,302,000 (-2.4%).
- Net income of 21,989,000 contributed positively to equity growth.
- Share repurchases of 89,684,000 reduced equity.
- New share issuances of 799,000 increased equity.
- Other factors increased equity by 25,594,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €21.99 Million | +1.28% |
| Share Repurchases | €89.68 Million | -5.23% |
| Share Issuances | €799.00K | +0.05% |
| Other Changes | €25.59 Million | +1.49% |
| Total Change | €- | -2.35% |
Book Value vs Market Value Analysis
This analysis compares ARRAIL GROUP LTD.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.07x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | €2.69 | €0.20 | x |
| 2023-03-31 | €2.77 | €0.20 | x |
| 2024-03-31 | €3.04 | €0.20 | x |
| 2025-03-31 | €3.04 | €0.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ARRAIL GROUP LTD. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.30%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.84x
- Recent ROE (1.28%) is above the historical average (-14.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -44.80% | -43.18% | 0.54x | 1.91x | €-857.50 Million |
| 2023 | -13.65% | -14.92% | 0.48x | 1.90x | €-380.98 Million |
| 2024 | 0.98% | 0.98% | 0.53x | 1.86x | €-158.35 Million |
| 2025 | 1.28% | 1.30% | 0.53x | 1.84x | €-149.40 Million |
Industry Comparison
This section compares ARRAIL GROUP LTD.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $5,325,238,317
- Average return on equity (ROE) among peers: -17.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ARRAIL GROUP LTD. (I1D) | €1.78 Billion | -44.80% | 0.77x | $111.29 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.85 Billion | 6.10% | 0.53x | $405.05 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $9.35 Million | -213.41% | 51.02x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $8.74 Billion | 1.39% | 0.74x | $656.44 Million |
| REVITALIST L.A.W. LTD (4DO) | $-11.05 Million | 0.00% | 0.00x | $744.60K |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.31 Billion | 4.15% | 1.31x | $19.28 Million |
| HYGEIA HC HLDGS DL-00001 (50I) | $6.78 Billion | 2.43% | 0.57x | $11.46K |
| COMPASS PATHW SP.ADR (5Y6) | $-52.85 Million | 0.00% | 0.00x | $657.30 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $14.79 Billion | 24.52% | 0.44x | $49.07K |
| Eifelhöhen-Klinik AG (EIF) | $14.69 Million | -6.59% | 3.60x | $10.05 Million |
| Fresenius Medical Care AG & Co. KGaA (FME) | $14.83 Billion | 3.37% | 1.29x | $10.01 Billion |
About ARRAIL GROUP LTD.
Arrail Group Limited operates dental clinics and hospitals in China. It operates through Arrail Dental and Rytime Dental segments. The company offers dental services, such as general dentistry, orthodontics, and implantology. It also engages in the wholesale of medical materials; investment holding; and hospital management business. Arrail Group Limited was founded in 1999 and is based in Beijing… Read more